Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-20-000037

EVP, Business Operations sold 37,423 shares at an average $66.82 ($2,500,531)

  • EVP, Business Operations acquired 37,423 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Havey Adam · EVP, Business Operations

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-17 Exercise or conversion : show line 1 in the form +20,414 $26.45 $539,950 54,670 D
2020-04-17 Sale : show line 2 in the form −20,414 $65.00 $1,326,910 34,256 D
2020-04-20 Exercise or conversion : show line 3 in the form +17,009 $30.86 $524,898 51,265 D
2020-04-20 Sale : show line 4 in the form −17,009 $69.00 $1,173,621 34,256 D
Open-market sales · 37,423 sh · avg $66.82 · $2,500,531

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-04-17 Sale : show line 5 in the form Stock Options (Right to Buy) −20,414 97,393 D
2020-04-20 Sale : show line 6 in the form Stock Options (Right to Buy) −17,009 80,384 D
Loading xslF345X03/wf-form4_158750711233940.xml…